Kl. Goh et al., Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients, J GASTR HEP, 15(8), 2000, pp. 910-914
Background: The aim of the present paper was to determine the efficacy and
tolerability of a 1-week treatment regimen consisting of pantoprazole and t
wo antibiotics: clarithromycin and amoxycillin, in the eradication of Helic
obacter pylori.
Methods: The patients selected had unequivocal evidence of H. pylori infect
ion based on urease test, culture and histology on antral and corpus biopsi
es obtained at endoscopy. Patients received pantoprazole 40 mg twice a day,
clarithromycin 500 mg twice a day and amoxycillin 1 g twice a day for 1 we
ek and were assessed for successful eradication at least 4 weeks after comp
letion of therapy by repeat gastroscopy and gastric biopsies. Eradication w
as defined as absence of bacteria in both antral and corpus biopsies tested
by culture, histology and urease test.
Results: One hundred and six patients were recruited for the study. The mea
n age was 48.0 years (range: 23-74 years). Four patients defaulted follow u
p and five patients were not compliant (taking less than 85%) with medicati
ons. Eradication rates on per-protocol analysis were: 88/97 (90.7%; 95% CI:
83.1-95.7); and on intention-to-treat analysis they were: 88/106 (83.0%; 9
5% CI: 75.9-90.2). Side-effects were in general mild and tolerable: 57 of 1
06 (53.7%) patients complained of a bitter taste; 15 (14.1%) complained of
giddiness; 10 (9.4%) complained of increased abdominal pain; 11 (11.5%) com
plained of lethargy and 16 (15.1%) complained of loose motions. Pre-treatme
nt metronidazole resistance was encountered in 57/74 strains (77.0%). Clari
thromycin resistance was not encountered in any of the strains.
Conclusions: The pantoprazole 1-week triple therapy with amoxycillin and cl
arithromycin is effective in H. pylori eradication. The treatment was well
tolerated by patients. Metronidazole resistance was reported in a high perc
entage of strains isolated from patients. Clarithromycin resistance was, ho
wever, nor, detected in any of the strains. (C) 2000 Blackwell Science Asia
Pty Ltd.